CNSPCNS Pharmaceuticals, Inc.

Nasdaq cnspharma.com


$ 0.17 $ 0.03 (17.95 %)    

Tuesday, 20-Aug-2024 15:59:52 EDT
QQQ $ 480.15 $ -1.01 (-0.21 %)
DIA $ 408.54 $ -0.55 (-0.13 %)
SPY $ 558.65 $ -0.91 (-0.16 %)
TLT $ 98.68 $ 0.78 (0.8 %)
GLD $ 232.46 $ 0.85 (0.37 %)
$ 0.1702
$ 0.15
$ 0.17 x 1,600
-- x --
$ 0.15 - $ 0.19
$ 0.10 - $ 137.50
11,286,894
na
64,105
$ 49.77
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-14-2024 06-30-2024 10-Q
2 05-15-2024 03-31-2024 10-Q
3 04-01-2024 12-31-2023 10-K
4 11-14-2023 09-30-2023 10-Q
5 08-14-2023 06-30-2023 10-Q
6 05-15-2023 03-31-2023 10-Q
7 03-31-2023 12-31-2022 10-K
8 11-10-2022 09-30-2022 10-Q
9 08-12-2022 06-30-2022 10-Q
10 05-13-2022 03-31-2022 10-Q
11 03-03-2022 12-31-2021 10-K
12 11-12-2021 09-30-2021 10-Q
13 08-13-2021 06-30-2021 10-Q
14 05-13-2021 03-31-2021 10-Q
15 02-12-2021 12-31-2020 10-K
16 11-12-2020 09-30-2020 10-Q
17 08-10-2020 06-30-2020 10-Q
18 05-15-2020 03-31-2020 10-Q
19 03-12-2020 12-31-2019 10-K
20 12-20-2019 09-30-2019 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 cns-pharmaceuticals-q2-eps-672-up-from-5186-yoy

CNS Pharmaceuticals (NASDAQ:CNSP) reported quarterly losses of $(6.72) per share. This is a 87.04 percent increase over losses ...

 cns-pharmaceuticals-q2-2024-net-loss-reduced-to-25m-due-to-lower-cro-expenses-rd-costs-decrease-to-11m-ga-expenses-increase-to-14m-due-to-higher-legal-and-professional-fees

Cash Position At $1.5M With Additional $12.4M Raised Post-June 30; Sufficient Funds Through Q1 2025, Final Berubicin Trial Data...

 whats-going-on-with-cns-pharmaceuticals-stock-tuesday

CNS Pharmaceuticals entered into a exclusive license agreement with Cortice Biosciences.

 cns-pharmaceuticals-received-letter-from-nasdaq-notifying-co-that-it-had-regained-compliance-with-bid-price-rule

- SEC Filing

 why-nio-shares-are-trading-lower-by-over-8-here-are-other-stocks-moving-in-fridays-mid-day-session

Shares of NIO Inc. (NYSE:NIO) fell sharply during Friday's session after the company disclosed that Steven Wei Feng has res...

 cns-pharmaceuticals-stock-was-volatile-wednesday-what-you-need-to-know

CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) experienced significant movement in its share price Wednesday afternoon. Here's a ...

 cns-pharmaceuticals-announces-pricing-of-198m-registered-direct-offering-and-concurrent-private-placement-of-1425m-shares-of-common-stock-at-a-combined-purchase-price-of-139-per-share

CNS Pharmaceuticals, Inc.

 cns-pharmaceuticals-announces-pricing-of-registered-direct-offering-and-concurrent-private-placement-of-568k-shares-at-245share

CNS Pharmaceuticals, Inc. (NASDAQ:CNSP) ("CNS" or the "Company"), a biopharmaceutical company specializing in t...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION